COMPOSITION
Bupartek Injectable Solution is a clear, red coloured, sterile solution. Each ml contains 50 mg of buparvaquone.
INDICATIONS FOR USE
Bupartek Injectable Solution is used in cattle for the treatment of all forms of theileriosis caused by Theileria annulata, T. parva, T. mutans and T. sergenti. Bupartek Injectable Solution can be administered during the incubation period of the disease and after the clinical signs of the disease are apparent.
ADMINISTRATION ROUTES AND AMOUNTS
Unless advised otherwise by the veterinarian, Bupartek Injectable Solution is administered only by deep intramuscular injection to the neck at the dose of 2.5 mg/kg bw.
Practical dose: 1 ml / 20 kg bw
Generally, a single dose is sufficient, but in severe cases the same dose can be repeated after 48 or 72 hours. Injecting more than 10 ml solution to the same injection site is not recommended. Dose should be divided and injected into different sites in such conditions.
WITHDRAWAL PERIOD(S)
Cattle producing meat for human consumption should not be slaughtered during the treatment and for 42 days after the last treatment. Do not use in lactating cows producing milk for human consumption.
MARKETING PACKAGING
20 ml, 50 ml and 100 ml in amber coloured glass vials inside cardboard boxes.
